| Literature DB >> 32947958 |
Muhammad Babar Taj1,2, Muneera D F Alkahtani3, Uzma Ali4, Ahmad Raheel4, Walla Alelwani5, Afnan M Alnajeebi5, Nouf Abubakr Babteen5, Sadia Noor6, Heba Alshater7.
Abstract
The microbial resistance to current antibiotics is increasing day by day, which in turn accelerating the development of new effective drugs. Several studies have proved the high antimicrobial potential of the interaction of several organic ligands with a variety of metal ions. In the present study, a conventional method has been adopted in the synthesis of twelve new heteroleptic complexes of cobalt (II), nickel (II), copper (II) and zinc (II) using three aldimines, namely, (HL1 ((E)-2-((4-chloro-2-hydroxybenzylidene)amino)-3,4-dimethyl-5-phenylcyclopent-2-en-1-one), HL2 ((Z)-3-((4-chlorobenzylidene)amino)-4-hydroxy-5-nitrobenzenesulfonic acid) HL3 (2,2'-((1,2-phenylenebis(azaneylylidene))bis(methaneylylidene))diphenol)) as primary ligands, while phenyl glycine was the secondary ligand. The synthesized compounds were characterized by UV-vis, IR and multinuclear (1H and 13C) NMR spectroscopy, elemental analysis, and electrical conductance. The IR study revealed the coordination of the aldimine derivatives with the -OH and N atom of imine moiety. In contrary to this, the phenyl glycine coordinated to the metal ions via oxygen of carboxylate and nitrogen of the amino group. The spectroscopic analysis unveiled the tetrahedral geometry of the synthesized metal (II) complexes, except for ligand HL3 which exhibited octahedral geometry. The synthesized compounds generally showed antibacterial activity for all microbes, except Ni (II) complexes lacking sensitivity. Furthermore, to access the bioavailability, the synthesized complexes were screened for their solubilization in the micellar media of sodium lauryl sulphate. The metal complex-surfactant interaction was revealed by UV-vis spectroscopy and electrical conductivity measurements.Entities:
Keywords: antimicrobial; electronic spectroscopy; micellar solubilization; mixed chelation; stability constants
Year: 2020 PMID: 32947958 PMCID: PMC7570477 DOI: 10.3390/molecules25184252
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Synthesis of aldimine ligands (HL1–HL3) and metal complexes.
Electronic spectral data of ligands (HL1–3) and heteroleptic complexes (ML1–3Gly).
| Compound | Electronic Absorption Peaks (nm) | Type of Transition |
|---|---|---|
| HL1 | 347 | n→π*, π→π* |
| CoL1Gly | 724, 349.2, 262 | d-d, CT |
| NiL1Gly | 734, 348.2, 258 | d-d, π→π*, n→π |
| CuL1Gly | 734, 348.5, 260 | d-d, π→π* |
| ZnL1Gly | 349 | Intra-ligand transition |
| HL2 | 441, 358 | n→π* |
| CoL2Gly | 690, 476, 456 | d-d, CT (charge transfer) |
| NiL2Gly | 675, 507, 406, 303, 262 | d-d, CT, n→π*, π→π* |
| CuL2Gly | 680, 532, 441, 426 | d-d, CT |
| ZnL2Gly | 445 | Intra-ligand transition |
| HL3 | 334, 276 | n→π*, π→π* |
| CoL3Gly | 732, 419, 332, 256, 246 | d-d, CT, n→π*, π→π* |
| NiL3Gly | 640, 475, 377, 308, 246, 207 | d-d, CT, n→π*, π→π* |
| CuL3Gly | 657, 439 | d-d, Intra-ligand, n→π* |
| ZnL3Gly | 402, 293 | Intra-ligand transition |
Stability Constants of heteroleptic complexes (ML1–3Gly).
| Compound | Kst (kJ/mol) | Compound | Kst (kJ/mol) | Compound | Kst (kJ/mol) |
|---|---|---|---|---|---|
| CoL1Gly | 5.47 × 1012 | CoL2Gly | 1.65 × 1012 | CoL3Gly | 3.34 × 1013 |
| NiL1Gly | 1.78 × 1011 | NiL2Gly | 1.75 × 1012 | NiL3Gly | 4.58 × 1012 |
| CuL1Gly | 1.9 × 109 | CuL2Gly | 7.5 × 107 | CuL3Gly | 6.25 × 105 |
| ZnL1Gly | 2.95 × 1010 | ZnL2Gly | 8.21 × 108 | ZnL3Gly | 1.22 × 105 |
Antibacterial data of HL1–3, Gly and their heteroleptic complexes at 1 mg/mL concentration.
| Compound | Minimum Zone of Inhibition (mm) | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| HL1 | 24.5 | 17.3 | 27.3 | 17.3 | 13.9 | 16.8 |
| HL2 | 22.3 | 16.2 | 24.9 | 16.5 | 14.6 | 19.4 |
| HL3 | 24.1 | 15.5 | 23.6 | 18.4 | 16.1 | 20.3 |
| Gly | 14.9 | 13.2 | 23.0 | 11.5 | 13.7 | 17.0 |
| CoL1Gly | 31.0 | 19.5 | 24.4 | 18.6 | 20.1 | 26.0 |
| NiL1Gly | 29.0 | 21.0 | R | R | 23.0 | 18.5 |
| CuL1Gly | 21.0 | 28.5 | 21.5 | 23.1 | 23.0 | 27.3 |
| ZnL1Gly | 27.7 | 23.0 | 23. 6 | 30.3 | 14.1 | 18.3 |
| CoL2Gly | 28.0 | 18.0 | 21.9 | 17.3 | 19.1 | 21.0 |
| NiL2Gly | 26.9 | 20.3 | R | R | 21.5 | 27.6 |
| CuL2Gly | 19.2 | 24.1 | 22.9 | 24.0 | 23.0 | 26.0 |
| ZnL2Gly | 26.1 | 22.4 | 22.2 | 28.8 | 17.1 | 16.0 |
| CoL3Gly | 32.2 | 21.6 | 24.4 | 18.6 | 20.1 | 28.1 |
| NiL3Gly | 30.3 | 23.6 | R | R | 25.4 | 30.0 |
| CuL3Gly | 23.1 | 29.7 | 23.1 | 25.0 | 26.2 | 29.2 |
| ZnL3Gly | 27.4 | 24.4 | 25.1 | 32.1 | 16.4 | 18.3 |
| + Ciprofloxacin | 33.0 | 32.0 | 36.0 | 26.0 | 29.0 | 23.0 |
| –(CH3)2SO | R | R | R | R | R | R |
R: No bacterial growth inhibition was observed; +: standard drug.
Figure 1Antibacterial activity of CoL1Gly against different bacterial strains.
Antifungal data of HL, Gly and Gly’s heteroleptic complexes at 1 mg/mL concentration.
| Compound | Minimum Zone of Inhibition (mm) | ||
|---|---|---|---|
|
|
|
| |
| HL1 | 22.7 | 28.7 | 26.3 |
| HL2 | 23.2 | 29.1 | 29.4 |
| HL3 | 24.7 | 27.6 | 28.6 |
| Gly | 16.0 | 19.8 | 13.6 |
| CoL1Gly | 25.6 | 24.1 | 26.5 |
| NiL1Gly | 14.5 | 24.2 | – |
| CuL1Gly | 22.2 | 24.1 | 24.7 |
| ZnL1Gly | 17.3 | 25.3 | – |
| CoL2Gly | 24.6 | 29.3 | 27.9 |
| NiL2Gly | 14.4 | 23.1 | – |
| CuL2Gly | 24.2 | 24.5 | 26.1 |
| ZnL2Gly | 13.0 | 26.0 | – |
| CoL3Gly | 25.1 | 27.1 | 28.6 |
| NiL3Gly | 16.5 | 24.1 | – |
| CuL3Gly | 23.9 | 27.5 | 25.5 |
| ZnL3Gly | 18.0 | 28.1 | – |
| + Fluconazole | 36.0 | 29.0 | 39.3 |
| –(CH3)2SO | – | – | – |
+: standard drug.
Figure 2Plots of conductivity and differential conductivity vs. (sodium lauryl sulfate) SLS concentrations.
Calculated micellar parameter for the interaction of complexes with SLS.
| System | CMC (mM) | ∆Gm (kJ/mol) | β |
|---|---|---|---|
| SLS | 8.3 | −38.39 | 0.243 |
| CoL1Gly/SLS | 10.52 | −33.79 | 0.426 |
| CoL2Gly/SLS | 9 | −28.11 | 0.7 |
| CoL3Gly/SLS | 9.56 | −27.11 | 0.737 |
| NiL3Gly/SLS | 10.83 | −31.072 | 0.532 |
Figure 3Plots of simple and differential absorbance vs. SLS concentrations.
Partitioning and binding parameters of selected complexes in micellar media.
| Complex | Kx (dm3/mol) | ∆Gp (kJ/mol) | Kb (dm3/mol) | ∆Gb (kJ/mol) |
|---|---|---|---|---|
| CoL1Gly | 137 | −12.19 | 190 | −13 |
| CoL2Gly | 27,400 | −25.31 | 325 | −14.25 |
| CoL3Gly | 50,000 | −26.8 | 58.5 | −10.08 |
| NiL3Gly | 956 | −17 | 80 | −10.85 |
Figure 4Proposed locus of metal complexes in the micelles of SLS.